Literature DB >> 21536980

Distinguishing between major depressive disorder and obsessive-compulsive disorder in children by measuring regional cortical thickness.

Erin Fallucca1, Frank P MacMaster, Joseph Haddad, Phillip Easter, Rachel Dick, Geoffrey May, Jeffrey A Stanley, Carrie Rix, David R Rosenberg.   

Abstract

CONTEXT: Cortical abnormalities have been noted in previous studies of major depressive disorder (MDD).
OBJECTIVE: To hypothesize differences in regional cortical thickness among children with MDD, children with obsessive-compulsive disorder (OCD), and healthy controls.
DESIGN: Cross-sectional study of groups.
SETTING: Children's Hospital of Michigan in Detroit. PARTICIPANTS: A total of 24 psychotropic drug-naive pediatric patients with MDD (9 boys and 15 girls), 24 psychotropic drug-naive pediatric outpatients with OCD (8 boys and 16 girls), and 30 healthy controls (10 boys and 20 girls). INTERVENTION: Magnetic resonance imaging. MAIN OUTCOME MEASURE: Cortical thickness.
RESULTS: In the right hemisphere of the brain, the pericalcarine gyrus was thinner in patients with MDD than in outpatients with OCD (P = .002) or healthy controls (P = .04), the postcentral gyrus was thinner in patients with MDD than in outpatients with OCD (P = .002) or healthy controls (P = .02), and the superior parietal gyrus was thinner in patients with MDD than in outpatients with OCD (P = .008) or healthy controls (P = .03). The outpatients with OCD and the healthy controls did not differ in these regions of the brain. The temporal pole was thicker in patients with MDD than in outpatients with OCD (P < .001) or healthy controls (P = .01), both of which groups did not differ in temporal pole thickness. The cuneus was thinner in patients with MDD than in outpatients with OCD (P = .008), but it did not differ from that in healthy controls. In the left hemisphere, the supramarginal gyrus was thinner in both patients with MDD (P = .04) and outpatients with OCD (P = .01) than in healthy controls, and the temporal pole was thicker in patients with MDD than in both healthy controls and outpatients with OCD (P < .001).
CONCLUSIONS: To our knowledge, this is the first study to explore cortical thickness in pediatric patients with MDD. Although differences in some regions of the brain would be expected given neurobiological models of MDD, our study highlights some unexpected regions (ie, supramarginal and superior parietal gyri) that merit further investigation. These results underscore the need to expand exploration beyond the frontal-limbic circuit.

Entities:  

Mesh:

Year:  2011        PMID: 21536980      PMCID: PMC4777351          DOI: 10.1001/archgenpsychiatry.2011.36

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  56 in total

1.  Quantitative evaluation of LDDMM, FreeSurfer, and CARET for cortical surface mapping.

Authors:  Jidan Zhong; Desiree Yee Ling Phua; Anqi Qiu
Journal:  Neuroimage       Date:  2010-04-08       Impact factor: 6.556

2.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

3.  Regional 133xenon cerebral blood flow and cerebral 99mTc-HMPAO uptake in patients with obsessive-compulsive disorder before and during treatment.

Authors:  R T Rubin; J Ananth; J Villanueva-Meyer; P G Trajmar; I Mena
Journal:  Biol Psychiatry       Date:  1995-10-01       Impact factor: 13.382

4.  Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder.

Authors:  Jun Soo Kwon; Jae-Jin Kim; Dong Woo Lee; Jae Sung Lee; Dong Soo Lee; Myung-Sun Kim; In Kyoon Lyoo; Maeng Je Cho; Myung Chul Lee
Journal:  Psychiatry Res       Date:  2003-01-20       Impact factor: 3.222

5.  An MRI study of the superior temporal subregions in patients with current and past major depression.

Authors:  Tsutomu Takahashi; Murat Yücel; Valentina Lorenzetti; Mark Walterfang; Yasuhiro Kawasaki; Sarah Whittle; Michio Suzuki; Christos Pantelis; Nicholas B Allen
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-10-13       Impact factor: 5.067

6.  MRI study of the pituitary gland in adolescent depression.

Authors:  Frank P MacMaster; Vivek Kusumakar
Journal:  J Psychiatr Res       Date:  2004 May-Jun       Impact factor: 4.791

7.  Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study.

Authors:  Ethan A Smith; Aileen Russell; Elisa Lorch; S Preeya Banerjee; Michelle Rose; Jennifer Ivey; Rashmi Bhandari; Gregory J Moore; David R Rosenberg
Journal:  Biol Psychiatry       Date:  2003-12-15       Impact factor: 13.382

8.  Pituitary gland volume in adolescent and young adult bipolar and unipolar depression.

Authors:  Frank P MacMaster; Ronald Leslie; David R Rosenberg; Vivek Kusumakar
Journal:  Bipolar Disord       Date:  2008-02       Impact factor: 6.744

9.  Gray matter differences between pediatric obsessive-compulsive disorder patients and high-risk siblings: a preliminary voxel-based morphometry study.

Authors:  Andrew R Gilbert; Matcheri S Keshavan; Vaibhav Diwadkar; Jeffrey Nutche; Frank Macmaster; Phillip C Easter; Christian J Buhagiar; David R Rosenberg
Journal:  Neurosci Lett       Date:  2008-02-12       Impact factor: 3.046

10.  Hippocampal volume in early onset depression.

Authors:  Frank P MacMaster; Vivek Kusumakar
Journal:  BMC Med       Date:  2004-01-29       Impact factor: 8.775

View more
  28 in total

1.  Development and evaluation of a multimodal marker of major depressive disorder.

Authors:  Jie Yang; Mengru Zhang; Hongshik Ahn; Qing Zhang; Tony B Jin; Ien Li; Matthew Nemesure; Nandita Joshi; Haoran Jiang; Jeffrey M Miller; Robert Todd Ogden; Eva Petkova; Matthew S Milak; Mary Elizabeth Sublette; Gregory M Sullivan; Madhukar H Trivedi; Myrna Weissman; Patrick J McGrath; Maurizio Fava; Benji T Kurian; Diego A Pizzagalli; Crystal M Cooper; Melvin McInnis; Maria A Oquendo; Joseph John Mann; Ramin V Parsey; Christine DeLorenzo
Journal:  Hum Brain Mapp       Date:  2018-08-16       Impact factor: 5.038

2.  Fetal exposure to maternal depressive symptoms is associated with cortical thickness in late childhood.

Authors:  Curt A Sandman; Claudia Buss; Kevin Head; Elysia Poggi Davis
Journal:  Biol Psychiatry       Date:  2014-07-10       Impact factor: 13.382

3.  Structural alterations in patients with obsessive-compulsive disorder: a surface-based analysis of cortical volume, surface area and thickness.

Authors:  Oana Georgiana Rus; Tim Jonas Reess; Gerd Wagner; Michael Zaudig; Claus Zimmer; Kathrin Koch
Journal:  J Psychiatry Neurosci       Date:  2017-11       Impact factor: 6.186

4.  Cortical thickness is not associated with current depression in a clinical treatment study.

Authors:  Greg Perlman; Elizabeth Bartlett; Christine DeLorenzo; Myrna Weissman; Patrick McGrath; Todd Ogden; Tony Jin; Phillip Adams; Madhukar Trivedi; Benji Kurian; Maria Oquendo; Melvin McInnis; Sarah Weyandt; Maurizio Fava; Crystal Cooper; Ashley Malchow; Ramin Parsey
Journal:  Hum Brain Mapp       Date:  2017-06-08       Impact factor: 5.038

Review 5.  Toward dysfunctional connectivity: a review of neuroimaging findings in pediatric major depressive disorder.

Authors:  Leslie A Hulvershorn; Kathryn Cullen; Amit Anand
Journal:  Brain Imaging Behav       Date:  2011-12       Impact factor: 3.978

6.  Ventromedial prefrontal cortex thinning in preschool-onset depression.

Authors:  Natasha Marrus; Andrew Belden; Tomoyuki Nishino; Ted Handler; J T Ratnanather; Michael Miller; Deanna Barch; Joan Luby; Kelly Botteron
Journal:  J Affect Disord       Date:  2015-03-27       Impact factor: 4.839

7.  Cortical Abnormalities Associated With Pediatric and Adult Obsessive-Compulsive Disorder: Findings From the ENIGMA Obsessive-Compulsive Disorder Working Group.

Authors:  Premika S W Boedhoe; Lianne Schmaal; Yoshinari Abe; Pino Alonso; Stephanie H Ameis; Alan Anticevic; Paul D Arnold; Marcelo C Batistuzzo; Francesco Benedetti; Jan C Beucke; Irene Bollettini; Anushree Bose; Silvia Brem; Anna Calvo; Rosa Calvo; Yuqi Cheng; Kang Ik K Cho; Valentina Ciullo; Sara Dallaspezia; Damiaan Denys; Jamie D Feusner; Kate D Fitzgerald; Jean-Paul Fouche; Egill A Fridgeirsson; Patricia Gruner; Gregory L Hanna; Derrek P Hibar; Marcelo Q Hoexter; Hao Hu; Chaim Huyser; Neda Jahanshad; Anthony James; Norbert Kathmann; Christian Kaufmann; Kathrin Koch; Jun Soo Kwon; Luisa Lazaro; Christine Lochner; Rachel Marsh; Ignacio Martínez-Zalacaín; David Mataix-Cols; José M Menchón; Luciano Minuzzi; Astrid Morer; Takashi Nakamae; Tomohiro Nakao; Janardhanan C Narayanaswamy; Seiji Nishida; Erika Nurmi; Joseph O'Neill; John Piacentini; Fabrizio Piras; Federica Piras; Y C Janardhan Reddy; Tim J Reess; Yuki Sakai; Joao R Sato; H Blair Simpson; Noam Soreni; Carles Soriano-Mas; Gianfranco Spalletta; Michael C Stevens; Philip R Szeszko; David F Tolin; Guido A van Wingen; Ganesan Venkatasubramanian; Susanne Walitza; Zhen Wang; Je-Yeon Yun; Paul M Thompson; Dan J Stein; Odile A van den Heuvel
Journal:  Am J Psychiatry       Date:  2017-12-15       Impact factor: 18.112

8.  Reduced nucleus accumbens reactivity and adolescent depression following early-life stress.

Authors:  B Goff; D G Gee; E H Telzer; K L Humphreys; L Gabard-Durnam; J Flannery; N Tottenham
Journal:  Neuroscience       Date:  2012-12-20       Impact factor: 3.590

9.  Structural neural markers of response to cognitive behavioral therapy in pediatric obsessive-compulsive disorder.

Authors:  David Pagliaccio; Jiook Cha; Xiaofu He; Marilyn Cyr; Paula Yanes-Lukin; Pablo Goldberg; Martine Fontaine; Moira A Rynn; Rachel Marsh
Journal:  J Child Psychol Psychiatry       Date:  2019-12-31       Impact factor: 8.982

10.  Improving mood with psychoanalytic and cognitive therapies (IMPACT): a pragmatic effectiveness superiority trial to investigate whether specialised psychological treatment reduces the risk for relapse in adolescents with moderate to severe unipolar depression: study protocol for a randomised controlled trial.

Authors:  Ian M Goodyer; Sonya Tsancheva; Sarah Byford; Bernadka Dubicka; Jonathan Hill; Raphael Kelvin; Shirley Reynolds; Christopher Roberts; Robert Senior; John Suckling; Paul Wilkinson; Mary Target; Peter Fonagy
Journal:  Trials       Date:  2011-07-13       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.